CMS Issues Guidance to Manufacturers

Yesterday, the Centers for Medicare & Medicaid Services (CMS) released guidance to manufacturers through Manufacturer Release #103 regarding the treatment of biosimilar biologics as authorized generics. This Manufacturer Release is available for download at the following link: https://www.medicaid.gov/Medicaid-CHIP-Program-Information/By-Topics/Benefits/Prescription-Drugs/Program-Releases.html.